Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Arash Aryana

Clinical Cardiac Electrophysiology Sacramento, CA Medical Doctor

NPI 1548279672 CMS profile 205579

3941 J St, Ste 260, Sacramento, CA 95819

Open in the dashboard

General payments

$383,444

539 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,967,094 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Arash Aryana of Sacramento, CA is reported in the CMS Open Payments database as having received $383,444 across 539 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,967,094 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $25,802 70
2024 General $29,349 82
2023 General $46,583 76
2022 General $25,273 64
2021 General $34,586 41
2020 General $88,389 71
2019 General $133,462 135

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Arash Aryana
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Arash Aryana were reported at $25,802. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Arash Aryana Clinical Cardiac Electrophysiology median Middle half National median
2019 $133,462 $2,361 $585–$8,260 $163
2020 $88,389 $993 $247–$4,351 $114
2021 $34,586 $1,185 $326–$4,739 $132
2022 $25,273 $2,073 $554–$6,789 $149
2023 $46,583 $2,568 $759–$8,159 $160
2024 $29,349 $2,557 $703–$7,403 $164
2025 $25,802 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $132,097 151 payments
  2. Biosense Webster, Inc. $65,557 82 payments
  3. Medtronic Vascular, Inc. $59,301 76 payments
  4. Boston Scientific Corporation $29,347 63 payments
  5. Janssen Pharmaceuticals, Inc $29,163 30 payments
  6. Medtronic, Inc. $25,938 83 payments
  7. Medical Device Business Services, Inc. $18,650 8 payments
  8. Philips Electronics North America Corporation $11,654 6 payments
  9. Atricure, Inc. $6,235 5 payments
  10. Biotronik Inc. $4,846 20 payments
  11. Other $657 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $184,299 57 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $110,682 42 payments
  3. Travel and Lodging $57,414 111 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $16,800 4 payments
  5. Food and Beverage $13,807 321 payments
  6. Education $277 3 payments
  7. Gift $166 1 payment
Products named General payments · program years 2019–2025
  1. Agilis NxT EP Introducer Cardiac Arrhythmias and Heart Failure $59,833 26 payments
  2. Carto 3 System $53,877 22 payments
  3. Arctic Front $42,137 55 payments
  4. AGILIS Electrophysiology $35,272 14 payments
  5. XARELTO $29,163 30 payments
  6. Carto 3 $16,781 34 payments
  7. Spectranetics Undiv $11,654 6 payments
  8. Agilis NxT EP Introducer Electrophysiology $8,800 2 payments
  9. Carto Smarttouch $7,281 3 payments
  10. AGILIS Structural Heart $7,142 6 payments
  11. Other $42,714 256 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

341

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$209,558

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

68%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 139 $119,612
Xarelto Rivaroxaban Brand 62 $62,310
Multaq Dronedarone Hcl Brand 19 $23,749
Flecainide Acetate Generic 19 $2,305
Amiodarone Hcl Generic 40 $783
Metoprolol Succinate Generic 25 $385
Sotalol Sotalol Hcl Brand 12 $325
Warfarin Sodium Generic 14 $65
Metoprolol Tartrate Generic 11 $25

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 80 billing codes

Paid by Medicare

$644,950

Medicare's payments for the services billed

Medicare patients

1,000

Average age 78

Services billed

4,372

439 women, 561 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 48%
Heart failure 47%
Arthritis 47%
Chronic kidney disease 35%
Diabetes 33%
COPD 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

539 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record